Pediatric Cancer Clinical Trials in Memphis, Tennessee

6 studies are recruiting for pediatric cancer in Memphis, Tennessee right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)

   Papillary thyroid cancer (PTC) is the most common form of differentiated thyroid cancer (DTC). The traditional first line treatment for patients with advanced DTC after surgical resection is radioactive iodine (RAI) therapy. However, less than a quarter of patients with lung metastases will achieve…

   Stage

   Phase 2

   Ages

   2 to 25

   Site

   St. Jude Children's Research Hospital, Memphis, Tennessee

   Locations

   5 in total

   Run by

   Children's Hospital of Philadelphia

   See if you can join NCT06458036 on ClinicalTrials.gov

2. Response to Influenza Vaccination in Pediatric Oncology Patients

   Influenza infection occurring during oncologic treatment or following hematopoietic cell transplantation (HCT) is associated with increased risk of morbidity in the form of lower respiratory tract infection (LRTI) and mortality relative to otherwise healthy patients. The study participants have bee…

   Stage

   Not phased

   Ages

   Up to 18

   Site

   St. Jude Children's Research Hospital, Memphis, Tennessee

   Run by

   St. Jude Children's Research Hospital

   See if you can join NCT05384288 on ClinicalTrials.gov

3. Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients

   This is a phase I/II study to evaluate the safety of combining intravenous (IV) atezolizumab and bevacizumab every three weeks, with daily oral cyclophosphamide and pharmacokinetic (PK)-guided sorafenib in children and adolescent and young adults (AYA) with relapsed or refractory solid malignancies…

   Stage

   Phase 1

   Ages

   Up to 30

   Site

   St. Jude Children's Research Hospital, Memphis, Tennessee

   Locations

   2 in total

   Run by

   St. Jude Children's Research Hospital

   See if you can join NCT05468359 on ClinicalTrials.gov

4. Targeted Therapy to Increase RAI Uptake in Metastatic DTC

   Papillary thyroid cancer (PTC) is a common type of differentiated thyroid cancer (DTC) in children and represents the second most common cancer in adolescent females. Recently targeted drugs that block many of the genetic drivers of DTC have become available. While Investigators know that these dru…

   Stage

   Not phased

   Ages

   0 and older

   Site

   St. Jude Children's Research Hospital, Memphis, Tennessee

   Locations

   9 in total

   Run by

   Children's Hospital of Philadelphia

   See if you can join NCT05024929 on ClinicalTrials.gov

5. Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer

   Papillary thyroid cancer (PTC) is the most common form of differentiated thyroid cancer (DTC). The traditional first line treatment for patients with advanced DTC after surgical resection is radioactive iodine (RAI) therapy. However, less than a quarter of patients with lung metastases will achieve…

   Stage

   Phase 2

   Ages

   2 to 99

   Site

   St. Jude Children's Research Hospital, Memphis, Tennessee

   Locations

   5 in total

   Run by

   Children's Hospital of Philadelphia

   See if you can join NCT05783323 on ClinicalTrials.gov

6. Childhood Cancer Predisposition Study (CCPS)

   The Childhood Cancer Predisposition Study (CCPS) is a multi-center, longitudinal, observational study that will collect clinical and biological data and specimens from children with a cancer predisposition syndromes (CPS) and their relatives. The central hypothesis is that studying individuals at h…

   Stage

   Not phased

   Ages

   Any age

   Site

   St. Jude Children's Research Hospital, Memphis, Tennessee

   Locations

   7 in total

   Run by

   Emory University

   See if you can join NCT04511806 on ClinicalTrials.gov